The discovery of streptomycin by Schatz, Bugie, and Waksman (1944) , followed by the introduction of para-amino salicylic acid (P.A.S.) (Lehmann, 1946) and of isoniazid (Robitzek and Selikoff, 1952) , completely revolutionized the treatment of pulmonary tuberculosis. With preliminary antibacterial treatment using combinations of these agents, artificial pneumothorax and thoracoplasty became relatively safe procedures and shorter periods of bed rest were necessary. The results of surgical resection improved enormously, with a high proportion of successes and a low complication rate (Bickford, Edwards, Esplen, Gifford, and Thomas, 1952; Thompson, Savage, and Rosser, 1954) , and operation came to be regarded as an essential part of treatment in most patients with extensive disease unsuitable for, or inadequately controlled by, other means. The persistence of cavitation was accepted as the strongest indication for operation, but resection or thoracoplasty continued to be widely employed as an " insurance " measure for the future in patients with lesions of the solid focus type, or in whom cavities had closed with preliminary treatment.
As experience was gained with the prolonged administration of combinations of the antibacterial agents, their remarkable efficiency was more and more apparent. It became increasingly doubtful if " insurance " surgery was necessary, or if even the persistence of cavitation was a clear indication for operation. The present investigation was planned in an attempt to clarify these points.
MATERIAL AND METHOD
The material is drawn from a population of one million, and all patients coming under our care between January, 1954, and December, 1956, were reviewed for the present investigation.
The principal purpose was to establish whether insurance " surgery was desirable for patients in whom cavities had already closed. We therefore included for study all patients with cavitary disease.
and sputum containing tubercle bacilli, who had achieved sputum conversion and cavity closure during an arbitrary period of six months' antibacterial treatment; these were divided into two groups depending on whether or not surgery was carried out. At the onset we believed that surgery should normally be advised where cavitation persisted after six months' antibacterial treatment, and patients who had surgery for cavitated disease have not been studied. It became clear, however, that a large number of patients in whom cavities persisted after the sputum had become negative remained well in spite of not having surgery, and these have been studied as a third group. Thus there were three groups of patients: Group A, patients with cavity closure after six months' antibacterial treatment, followed by surgery; Group B, patients with cavity closure after six months, without surgery; Group C, patients with persisting cavity after six months, without surgery.
All were treated with two or three of the standard antibacterial agents in the rdgimes now accepted in Great Britain, except a small number who had intermittent streptomycin with daily P.A.S. or isoniazid for short periods early in the investigation. A substantial number had been given antibacterial treatment before coming under our care, but frequently no details were available of the treatment given.
After their initial treatment in hospital, where sputum was examined monthly by smear and culture, all patients had chest radiographs and sputum examinations at least quarterly. In the absence of sputum, laryngeal swabs were taken.
The criteria for bacterial resistance were growth of not less than 20 colonies on a Lowenstein-Jensen by smear or culture from sputum or laryngeal swab on one or more occasions.
At the present time 390 patients have been followed from three to seven years from the start of chemotherapy: 60 patients were excluded who fulfilled the criteria except that we were unable to confirm a positive sputum at the onset, 37 have been followed from two to three years, 99 for three to four years, and 251 for over four years. Three patients died in under two years. RESULTS AGE DISTRIBUTION.-It is seen from Fig. 1 that there is no great difference between Group A and B as regards age distribution, the peak being from 15 to 34 years in each case, whereas in Group C the majority are aged over 35.
EXTENT OF DISEASE.-This is classified according to the number of zones involved (FosterCarter, Myers, Goddard, Young, and Benjamin, 1952) (Fig. 2) .
One zone is shown in the left, two to three zones in the middle, and four or more zones in the righthand column. All three groups have a similar proportion with intermediate disease, but Group C has rather more patients with extensive disease and rather fewer with limited than the other two.
TOTAL CAVITY DIAMETER.-In Fig. 3 the lefthand column shows those with cavitation of less than 2 cm., the middle with 2 to 5 cm., and the right with more than 5 cm. Again Group C has rather more patients with large cavities and fewer with small than the other two groups.
Considering the extent of disease and total cavity diameter together, it appears that Groups A and B are of overall comparable severity, for, In Group A cavity closure was followed by surgery. Of a total of 97 patients, 96 are alive and well, with one (non-tuberculous) death. Ninetyfour of these patients are working and none has relapsed. Fifty were treated by resection of residual disease and 47 by thoracoplasty.
In Group B cavity closure was followed by antibacterial treatment alone. Of a total of 185 patients 175 are alive and well, and 167 of these are working. There have been nine deaths, all non-tuberculous, and three relapses.
In Group C there was persistent cavitation with negative sputum, and surgery was not carried out. Ninety-eight patients out of a total of 108 are alive and well, though only 57 are working. These patients had more extensive disease and were older than those in the other two groups. Three patients have relapsed, one of whom died of tuberculosis. There were seven non-tuberculous deaths in this group, making eight in all.
The causes of death are analysed in Table II . The one death in Group A was due to cerebral thrombosis three and a half years after surgery.
Of the nine deaths in Group B, two were due to cor pulmonale and heart failure, two to cardiac infarction, three to carcinoma of the bronchus, one to generalized carcinomatosis, and one to fulminating septic pneumonia which was confirmed at necropsy. In no instance was there evidence of reactivation of the tuberculosis.
In Group C six patients died of cor pulmonale and heart failure without radiological or bacteriological evidence of reactivation of tuberculosis; one committed suicide, and one died of progressive tuberculosis, the only tuberculous death in the whole series of 390 patients.
Taking the three groups together, eight died from cor pulmonale and heart failure, nine from unrelated causes, and one from active tuberculosis. Sixteen of the 18 patients died at home and necropsies were not obtained. The diagnosis in two of the patients who died of carcinoma was proved by biopsy, and necropsies were done on the patient who committed suicide and the patient with fulminating pneumonia. All Of the three patients in Group C, one had three positive cultures nine months after stopping a twoyear course of treatment. The organisms were resistant to all three agents, and she died shortly after leaving hospital at her own request while still culture-positive.
The second produced positive cultures resistant to P.A.S. and isoniazid after three and a half years' continuous treatment, whilst the third relapsed two months after stopping three years' continuous treatment, the organisms showing resistance to all three agents.
Five of the six patients relapsing either had had treatment with a single agent or had failed to take their treatment regularly, and all showed some degree of bacterial resistance. The sixth, who had a radiological relapse only, would doubtless have done as well without surgery, as the specimen produced no viable organisms. From our experience with these patients, we think that the quality of antibacterial treatment is of more importance than its duration.
Our knowledge of many of the remaining, i.e., non-relapsing, patients is incomplete due to lack of information about pre-treatment sensitivities and about antibacterial treatment given before they came under our care.
DURATION OF ANTIBACTERIAL TREATMENT.-The duration of treatment is shown in Fig. 4 Until recently, the outlook for patients with persistent cavitation would have been considered unfavourable in spite of the achievement of sputum conversion. Not only was the average age of these patients considerably higher than in the other groups, but the disease was more extensive, the cavities were larger and they failed to close with prolonged antibacterial treatment and bed rest. In many of these patients the indications for surgery would have been considered very strong, and the group provides an exacting test for medical treatment. In spite of this the results were hardly less satisfactory than those obtained in the other two groups. All three patients who relapsed had had unsatisfactory rdgimes in the early stages and ultimately produced drug-resistant organisms in the sputum. These very encouraging results are in close accord with those reported in Great Britain by Douglas and Horne (1956) , who treated six patients with persistent cavitation, and with those of Wilson, Doyle, and Gardiner (1958) , who treated 40 similar patients using optimum drug regimes. The sputum of both these groups of patients became persistently negative for tubercle bacilli, and no relapses had occurred at that time.
Recent reports from the U.S.A. have been less encouraging. (1950, 1952, 1953, and 1955) and have been re-emphasized by Crofton (1959) . It is now generally accepted in Britain that it is essential to give daily streptomycin with isoniazid or P.A.S., or, alternatively, daily isoniazid and P.A.S. Many workers prefer to give all three agents together in the early months while the results of bacterial sensitivity tests are awaited, since resistance could develop on a two-drug regime if the bacilli were already resistant to one of those in use. This has been our policy in recent years.
Long-term antibacterial treatment was first widely adopted in the U.S.A. where, by 1951, the duration of twice-weekly streptomycin and P.A.S. therapy generally in use was 12 months or more (Mitchell and Bell, 1958) . In 1955, Hoyle, Nicholson, and Dawson in Britain described the early results of treating 142 patients with antituberculous drugs for at least nine months, and drew attention to the need for prolonged treatment. In a report concerning the later progress of this group, together with that of 51 other patients fulfilling the requirements for inclusion, Batten, Turner-Warwick, Hoyle, and Nicholson (1960) , while agreeing that the length of treatment required remains obscure, give their view that all cases of pulmonary tuberculosis, even when very slight, should receive at least two years' drug therapy.
STUDIES OF RESECTED SPECIMENS.-A good indication regarding the length of treatment required for the various types of tuberculous lesions is provided by studies of the histology and bacteriology of resected specimens, duly correlated with the results of tests of bacterial sensitivity and with the type and duration of treatment employed. Stewart, Turnbull, and Macgregor (1956) in a study of resected specimens found that, in patients with sensitive tubercle bacilli and caseous foci or cavitation, the longer the duration of effective treatment the less the likelihood of viable organisms persisting in the lesion. No viable bacilli were obtained from either type of lesion where treatment had been continued for 18 months or more. There was a close correlation between the healing of cavity walls and the results of bacteriological examination of the lesion. In contrast, in the group with sputum containing drug-resistant tubercle bacilli, 93-100% of the lesions contained viable bacilli regardless of the length of treatment. Although caseous foci were sterilized more readily than cavities, it was concluded that at least 12 to 18 months' treatment was essential in both conditions. Eade, Harrison, Large, Mackay-Dick, Reid, and Riddell (1959) studied the bacteriology of resected specimens from the lungs of 59 Gurkha soldiers after 10 to 25 months' treatment. In general they found a progressive decrease in positive cultures with increasing duration of chemotherapy. Five patients had persistent cavitation after periods of chemotherapy of more than nine months, and the resected specimens of three contained viable tubercle bacilli. The pre-operative laryngeal swab cultures of two of these, however, grew resistant tubercle bacilli. They considered that these findings, together with those of Keers, Riddell, and Reid (1956) and of Bell, Decker, and Raleigh (1957) , constitute a strong argument for resection in these " open-negative " patients. The regimes of treatment used in many patients in these series, however, have not been those generally recognized to be essential at the present time. Cotter, Foreman, and Seal (1958) studied the resected specimens of 218 patients and found acid-fast bacilli in 65% of the specimens, but tubercle bacilli were grown on culture in only 12%. After satisfactory treatment for at least eight months (average 121 months), no viable bacilli were found, whereas after long, indifferent, and bad regimes 12-18% of the resection specimens contained viable bacilli. No positive cultures were obtained from five resected specimens containing open cavities from patients who had had good antibacterial treatment. It was concluded that the development of bacterial resistance was an important factor in the recovery of bacilli from resected lesions, and that this was associated with bad antibacterial treatment. Edge and Bottrill (1959) found that 15% of resected specimens contained viable tubercle bacilli after a minimum period of six months of good treatment, whereas viable bacilli were found in 52% of specimens from 75 patients who had had unsatisfactory regimes. They found the sensitivity levels of the organisms from the preoperative cultures and from the resected specimens to be remarkably consistent, and they confirm the close relationship of resistance with the persistence of viable bacilli, and the very frequent association of both with unsatisfactory treatment.
These papers, therefore, suggest that sterilization of tuberculous lesions can be achieved, provided that the organisms are sensitive to the antibacterial agents, and provided that these are used in optimum dosage and combination and maintained for a long time: a minimum period of 18 months seems to be essential. Our 
CONCLUSIONS
In patients in whom the lung cavities have closed and sputum has ceased to contain tubercle bacilli during six months' antibacterial treatment, there is nothing to be gained from " insurance " surgery, provided the bacteria were initially fully sensitive to the main antibacterial agents and provided adequate treatment with these agents is maintained for at least 18 months. In the same way, in those patients in whom cavities have remained open and sputum has ceased to contain tubercle bacilli during six months' antibacterial treatment, there is probably nothing to be gained by surgical operation, provided the bacteria were originally fully sensitive. The length of antibacterial treatment necessary in this group may well be several years.
Medical treatment using optimum regimes for a period of at least 18 months is indicated in all patients with pulmonary tuberculosis caused by bacilli sensitive to the antibacterial agents. Surgical treatment, although carrying an increased risk in these circumstances, is probably indicated only when infection with resistant bacilli is proved. It may also be indicated for patients who cannot maintain an adequate r6gime of chemotherapy due to drug reactions or temperamental difficulties. In patients where the presence of resistant organisms can be suspected but remains unproven, it seems reasonable to await the outcome of medical treatment before advising for or against operation. Only permanent observation of medically treated patients will show whether or not other indications for surgical treatment will become re-established. SUMMARY Three hundred and ninety patients with cavitating pulmonary tuberculosis with tubercle bacilli in the sputum were divided into three groups according to treatment.
In all patients, the sputum converted to negative within six months of starting treatment.
All the relapses occurred in patients who had been treated with unsatisfactory antibacterial regimes in the earlier stages. All patients have been followed from three to seven years from the start of antibacterial treatment. During this period 18 have died, eight from pulmonary heart disease, nine from unrelated causes, and only one from active tuberculosis.
